NCT05047965Active, not recruitingEarly phase 1
An Investigational Scan (MRI With Dixon Based Sequences) in Detecting Prostate Cancer
Evaluation of MRI With Dixon Based Sequences in the Detection of Prostate Cancer
Source: ClinicalTrials.gov · Last updated 6 Oct 2026
Brief summary (registry, in English)
This trial studies the use of magnetic resonance imaging (MRI) with Dixon based imaging sequences in detecting prostate cancer. MRI uses radio waves and a powerful magnet linked to a computer to create detailed pictures of areas inside the body. Researchers hope to learn if using a modified MRI scan technique with Dixon based imaging sequencing will help to produce better images of prostate cancer than the standard of care MRI scan technique.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Early phase 1
- Study type
- Interventional
- Enrollment
- 65 (estimated)
- First submitted
- 8 Sept 2021
- Start date
- 25 Apr 2013
- Primary completion date
- 2 Feb 2027
- Lead sponsor
- M.D. Anderson Cancer Center
- Diseases
- Prostate cancer
- NCT number
- NCT05047965
What you commit to
- Study type: Interventional · Early phase 1
- Planned participants: 65
- From 25 Apr 2013 to the primary completion date, 2 Feb 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Known prior hormone ablation or radiation therapy (pelvic or prostate).
- Patients who do not want to undergo prostatectomy and prefer other therapy or surveillance.
- Contraindication to conventional MR imaging (e. g. metal implants, pace maker, etc.).
Who the study is looking for
- Biopsy proven prostate cancer patients who are scheduled to undergo prostatectomy.
- Patient who is scheduled to have a clinically indicated staging endorectal prostate MRI exam.
- Patients who have signed their informed consent form to undergo the study.
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| M D Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.